Medical device regulation in Israel is administered by the Medical Device Division of the Ministry of Health, commonly known as AMAR. The Israeli registration system places great weight on regulatory approvals from reference countries or regions, but this does not mean Israel does not review the product itself at all, nor that CE or FDA approval allows the product to be sold in Israel automatically.
Companies still need to determine the local applicant, the applicable registration route, reference-country approvals and actual sales status, quality system documents, product technical documentation, labelling requirements and import arrangements. After registration, they must also continuously manage the validity of reference-country certificates, product changes, renewals and post-market safety information.
For Chinese manufacturers, what really needs to be designed in advance is not a single application dossier, but the complete market access structure: who applies, on the basis of which approvals the application is made, who holds the registration, who is responsible for import, who maintains the certificate, and how these are handled when the certificate expires or the cooperation relationship changes.
Version note on the regulations and procedural documents cited in this article
This article is verified against official Israeli sources available as of 16 November 2026, mainly covering:
- Medical Equipment Law, 5772-2012.
- Medical Equipment Regulations (Registration of Medical Equipment in the Register and Renewal thereof), 5773-2013.
- AMAR declaration route registration procedure REG-2023/04 and registration certificate format procedure REG-2023/05.
- AMAR standard registration documentation requirements procedure REG-2024/03.
- AMAR fast-track registration procedure REG-2024/06.
- AMAR renewal procedure REG-2024/07.
- AMAR registration change procedure REG-2024/08.
Among these, REG-2024/03, REG-2024/07 and REG-2024/08 have been in force since 1 January 2025; the relevant documents were updated on 12 May 2025. For specific projects, always check the latest versions and forms on the Ministry of Health website before submission.
Note on legal texts: The official Hebrew text of Israeli laws and regulations is legally binding. English translations are provided for understanding and locating provisions only; where a translation is inconsistent with the Hebrew text, the official Hebrew text prevails.
Part 1 | Regulatory Foundation: Who Regulates, What Is Regulated, and How Devices Are Classified
Q01 Which authority regulates medical devices in Israel, and what is the legal basis?
Answer: Medical devices in Israel are managed by the Medical Device Division (AMAR) of the Ministry of Health, mainly covering the medical equipment register, review of registration applications, registration certificates and import approvals, registration changes and related post-market surveillance work.
The main legal framework includes:
- Medical Equipment Law, 5772-2012: establishes the registration system for medical equipment, the registration applicant, registration conditions, the application of reference-country approvals, regulatory measures and legal liability.
- Medical Equipment Regulations, 5773-2013: sets out registration application documentation, review periods, registration validity, renewal, changes, warehousing and transport, contact persons and labelling requirements.
- AMAR procedural documents: further specify the operational requirements for the declaration route, the fast-track routes, standard registration documentation, renewal and changes.
The Israeli registration system is not a simple automatic conversion based on reference-country approvals. Article 6(a) of the Law still requires the competent authority to consider the benefit-risk profile, effectiveness, safety, quality and appropriate manufacturing conditions of the product. The current AMAR REG-2024/03 also expressly requires applicants to submit technical documentation matching the product risk class and product type, and the competent authority may request additional information as needed for the review.
A more accurate understanding is therefore: Israel makes full use of the regulatory conclusions of reference countries to simplify part of the review, while retaining its own register management and the necessary safety, quality and effectiveness review.
Legal basis: Medical Equipment Law Articles 2, 3 and 6; Medical Equipment Regulations Articles 3 and 5; AMAR REG-2024/03.
Q02 Which products must be registered, and which can be exempted?
Answer: Whether a product falls within the scope of Israeli medical equipment is determined first by the definition in Article 1 of the Medical Equipment Law. The scope includes:
- Instruments used for medical treatment, and instruments or computer software required to operate such instruments; ‘instrument’ includes accessories, chemical substances, biological products and biotechnology products.
- Contact lenses.
- Electrical devices emitting ionising or non-ionising radiation used for cosmetic treatment.
Drugs as defined in the Pharmacists’ Regulations are outside the above definition of medical equipment and should be assessed under the corresponding pharmaceutical regulatory regime.
The Second Schedule to the Medical Equipment Law lists nine categories that do not require registration:
- Examination accessories, such as cotton swabs and wooden sticks used for non-invasive or oral examination;
- Elastic bandages;
- Dental floss;
- Non-sterile dressings;
- Disinfection materials used for non-medical equipment;
- Condoms, except condoms containing pharmaceutical substances;
- Feminine hygiene products;
- Cotton products;
- Scales for weighing the human body, except scales for premature infants and scales used for weighing substances.
In addition, Article 2(b) of the Law allows the Minister of Health, subject to statutory procedures, to exempt specific categories of products by order; Article 4 establishes a mechanism for obtaining permits to use or manufacture unregistered products in specific situations, for example necessary medical treatment, research, development and manufacturing (excluding sale), emergencies, export only, continued use by specific medical institutions, off-label use, clinical evaluation with a limited number of patients, and personal use.
Note: statutory exemptions, ministerial order exemptions and case-by-case permits are different legal mechanisms; a case-by-case permit must not be understood as regular market access for the product.
Legal basis: Medical Equipment Law Article 1, Article 2, Article 4 and the Second Schedule.
Q03 Does Israel have its own risk classification rules for medical devices?
Answer: The Israeli registration procedure mainly follows the US FDA and EU medical device classification systems, and determines the applicable route according to reference-country regulatory approvals. It should not be simplistically assumed that Israel performs no classification assessment at all, nor that products with CE or FDA approval need no local assessment.
Article 10 of the Medical Equipment Regulations provides that where a medical device is registered in several recognized countries, including the US FDA, the competent authority shall adopt the classification, registration conditions and registration period determined by the FDA.
This provision has clear conditions of application; it does not mean that whenever a product holds both CE and FDA documents, the FDA classification automatically replaces other classifications in all cases.
Current AMAR procedures mainly use the following classification expressions:
- FDA: Class I, Class II, Class III;
- EU medical devices: Class I, Class IIa, Class IIb, Class III;
- EU IVDs: the risk classes corresponding to the IVDD and the IVDR, including IVDR Class A, B, C and D.
In practice, applicants must truthfully state the classifications and approval status under the different regulatory authorities. Where classifications differ between authorities, confirm the classification and registration route applicable at AMAR before applying; do not choose the most favourable class for the application on your own.
Legal basis: Medical Equipment Regulations Article 10; AMAR REG-2024/03 and REG-2024/06.
Q04 Which countries are actually ‘Recognized States’? Does Japan count?
Answer: ‘Recognized State’ is defined in Article 1 of the Medical Equipment Law and the First Schedule. The current First Schedule lists 21 countries:
Austria, Australia, Italy, Iceland, Ireland, the United States, Belgium, the United Kingdom, Germany, Denmark, the Netherlands, Greece, Norway, New Zealand, Spain, Portugal, Finland, France, Canada, Sweden and Switzerland.
Note the following points:
- Japan, South Korea and Singapore are not on the First Schedule. Approvals from the PMDA, the MFDS or the Singapore HSA alone do not satisfy the conditions of the Israeli recognized-country route.
- Israel itself is not on the list of recognized states. Israeli domestic registration cannot substitute for a reference-country approval as a recognized-state approval.
- The EU is not a country in the First Schedule. The recognized states under the legal definition are the countries listed in the Schedule; the EU regulatory approval mentioned in the fast-track procedure is a route-level expression for the EU regulatory system, and ‘the EU’ must not be simply counted as one country when calculating the number of recognized states.
- Article 19 of the Law allows the Schedule to be adjusted through statutory procedures, so re-verify the list before project launch.
Legal basis: Medical Equipment Law Article 1, the First Schedule and Article 19.
Part 2 | Applicant and Documentation: Who Can Hold the Registration and What Must Be Submitted
Q05 Can a Chinese manufacturer hold the Israeli registration certificate itself?
Answer: A Chinese manufacturer cannot act directly as the Israeli registration applicant merely in its capacity as a company established in China. Under Article 3(b) of the Medical Equipment Law, a registration application must be submitted by an Israeli resident or a company registered in Israel.
In practice, an Israeli local company therefore usually acts as the applicant and the registration holder. The Chinese manufacturer provides the product, technical, quality and regulatory documentation, and agrees on the respective responsibilities with the local holder.
Also note: Article 3(e) of the Medical Equipment Law expressly states that the registration of medical equipment itself does not create any right in that equipment and does not derogate from existing rights. Registering the certificate in the name of the local holder does not by itself resolve the ownership of documentation, commercial interests and control of the certificate between the manufacturer and the holder.
The cooperation agreement should clearly address:
- Ownership, rights of use and access to the registration dossier and technical files;
- Division of responsibilities for registration applications, changes, renewals and regulatory enquiries;
- The manufacturer’s continuing obligations to support design, production, the quality system and safety information;
- Handover of documentation, cooperation in changing the registration holder and transition arrangements after termination of the cooperation;
- A prohibition on the holder abandoning, cancelling or restricting use of the certificate without agreement.
Legal basis: Medical Equipment Law Articles 3(b) and 3(e); Medical Equipment Regulations Article 2.
Q06 Must the Israeli local registration holder hold ISO 9001?
Answer: This cannot be judged by looking only at Article 20 of the Medical Equipment Regulations. It is necessary to distinguish the documentation requirements for the local applicant/holder from the requirements for the entity actually responsible for warehousing and transport.
First, the quality management system of the local applicant/holder. The current AMAR REG-2024/03 requires proof of the holder’s quality management system; accepted documents include ISO 9001 or GMP. Where a business licence is required under the business licensing legislation, the corresponding business licence documents must also be provided. It is therefore no longer accurate to say broadly that ‘the Israeli registration holder has no ISO 9001 requirement’.
Second, the warehousing and transport entity. Article 20 of the Medical Equipment Regulations requires that medical devices marketed in Israel be transported and stored by an entity approved by a body recognised by the competent authority as meeting ISO 9001 requirements and holding the applicable warehousing and transport business licence.
Third, the contact person and the qualified professional.
- Article 21 of the Regulations requires the applicant to designate in writing a contact person from among its employees, responsible for the registration application and for answering enquiries from the competent authority. The contact person is not a role that can casually be filled in name by an external consultant.
- Article 22 of the Regulations provides that for certain high-risk or special products, the contact person must also meet the qualified professional qualification requirements, and the qualified professional must be an Israeli resident.
| Product type | Qualified professional requirements |
|---|---|
| Life-support/life-sustaining equipment, implants | Physician, recognised bachelor’s degree in life sciences or medical sciences, or accredited biomedical engineer |
| Devices containing pharmaceutical substances, blood product processing equipment, devices containing animal-origin materials | The above, or a licensed pharmacist |
| Imaging equipment, devices emitting ionising or non-ionising radiation, laser equipment | The above, or an accredited electronics engineer, or a bachelor’s degree in physics |
Conclusion: the ISO 9001/GMP documentation requirements for the local holder, the ISO 9001 requirement for the warehousing and transport entity, and the professional qualification requirements for the contact person are three separate compliance matters and should be verified separately.
Legal basis: Medical Equipment Regulations Articles 20, 21 and 22; AMAR REG-2024/03.
Q07 What documents must be submitted with the registration application?
Answer: Article 3(a) of the Medical Equipment Regulations sets out 13 basic items of information and documents for the application, but these 13 items do not mean every product needs only 13 documents. The current AMAR REG-2024/03 additionally requires the corresponding technical documentation according to the product risk class, product type and reference-country approval status.
The basic content listed in Article 3(a) of the Regulations includes:
- Information on the Israeli local operating entity, its address, the contact person or qualified professional, and the applicable business licence number and validity period;
- Evidence of warehousing and transport conditions meeting Article 20 of the Regulations;
- Manufacturer and manufacturing site information, and evidence of manufacturing conditions meeting Article 19 of the Regulations;
- The full product name in Hebrew and English, the models covered by the application, and the physical, technical, medical and functional characteristics;
- Product indications, intended use and the purpose of use for which registration is sought;
- Names of import distributors and sub-suppliers;
- Whether the product contains pharmaceuticals, chemical substances, toxic substances or biological substances, and whether it emits ionising or non-ionising radiation;
- Evidence of foreign registration and, where applicable, certificates of actual sales issued by the relevant country;
- How product support and maintenance services are provided and the service provider information;
- Labelling, marking and packaging materials, and a draft instructions-for-use within the scope required by the competent authority;
- Information relating to the application fee;
- Declarations by the applicant and the manufacturer that the documentation is complete and truthful;
- Where the application is submitted by a qualified professional, the training certificate required by Article 22 of the Regulations.
Current submission requirements also focus on:
- Submitting the application through the electronic channel designated by AMAR; the current standard procedure requires the electronic application form and a compressed file package, with package size and format as specified in the current procedure.
- Proof of the registration holder’s quality management system: ISO 9001 or GMP; where applicable, the business licence.
- Quality system evidence for the manufacturer, the manufacturing sites and the sterilisation sites; AMAR procedures accept ISO 13485, GMP and equivalent evidence, with additional documentation requirements for scenarios such as suppliers/distributors.
- The manufacturer’s declaration, an explanation of global sales, and the applicable foreign regulatory approval documents.
- Product-type-specific documentation such as risk management, clinical evaluation, electrical safety, EMC, sterilisation, radiation safety, biocompatibility, IVD verification and validation, and software verification and validation.
Special note: the special requirements in Article 3(c) of the Medical Equipment Regulations on risk analysis, clinical evaluation, a summary of clinical trials and the opinions of two medical experts in the relevant field target devices manufactured in Israel that are not registered or approved for sale in a recognized state. This special clause must not be applied directly to all foreign-manufactured products without CE or FDA approval.
In addition, although Article 3(a)(11) of the Regulations retains the application fee documentation requirement, an official Ministry of Health announcement states that from 15 August 2022, no application fees are charged for registration, change and renewal applications. When completing forms, follow AMAR’s current forms and announcements; do not rely on outdated fee information.
Legal basis: Medical Equipment Regulations Article 3; AMAR REG-2024/03; Ministry of Health AMAR announcements.
Part 3 | Registration Routes, Review Timelines and Post-Registration Management
Q08 How many registration routes are there currently, and which products do they apply to?
Answer: AMAR currently operates mainly the declaration route, Fast 1, Fast 2 and the standard route. Applicability depends on the product risk class, the type of reference-country approval, and the actual sales history.
| Registration route | Main applicable products | Key prerequisites | Review time for new registrations |
|---|---|---|---|
| Declaration route | Medical devices Class I and low-risk IVDs (including applicable categories such as IVDR Class A) | The product is registered or approved for sale in a recognized state and actually sold there; declaration submitted per procedure | Officially announced as immediate registration, provided the documentation meets the requirements |
| Fast 1 | FDA Class II medical devices/IVDs; EU Class IIa medical devices; IVDD Self-Test or IVDR Class B IVDs | For the FDA route, only 510(k) or De Novo approvals are accepted, plus sales in the US in the last 4 months; the relevant EU classes require sales in a recognized state in the last 4 months | Up to 45 working days |
| Fast 2 | EU Class IIb medical devices; IVDD List B or IVDR Class C IVDs | Approvals from two mutually independent regulatory authorities, plus sales in recognized states in the last 6 months | Up to 60 working days |
| Standard route | Class III, IVDR Class D, and other products that do not meet the declaration or fast-track conditions | Submission of the corresponding technical documentation under the standard procedure, subject to AMAR review | Statutory base review period of 120 days; the period for supplementary documentation is counted separately |
Three points need special explanation:
- FDA Fast 1 does not apply to all FDA documents. REG-2024/06 makes clear that the FDA approval types include only 510(k) and De Novo. FDA establishment registration, product listing or other documents outside that scope cannot be taken as satisfying Fast 1.
- Fast 2 requires two mutually independent regulatory authorities. ‘Independent’ means that one authority’s approval is not built on the approval of the other recognized state. The EU and the FDA are the examples listed in the procedure; it should not be read as necessarily two countries, nor judged only by the fact that the company holds two certificates.
- FDA Fast 2 has a special rule on the place of sale. Where the product has FDA approval, actual sales in the US are not mandatory; the 6-month sales requirement may be met in another recognized state only.
Nor does the declaration route mean that AMAR has completed the same degree of technical review as the standard route. The AMAR declaration-route registration certificate expressly notes that registration is based on the holder’s declaration and that the product and documents have not undergone the Ministry of Health’s standard review. Applicants therefore remain responsible for the content of the declaration, product compliance and post-registration obligations.
Legal basis: AMAR REG-2023/04, REG-2024/06 and REG-2023/05.
Q09 How long does the review actually take? Does 120 days guarantee a certificate?
Answer: Distinguish the statutory base review period, the supplementary documentation period, and the working-day timelines of the fast-track routes.
- Standard route: Article 5(a) of the Medical Equipment Regulations provides that the competent authority shall reach a decision within 120 days from the date of submission. This 120-day period is the statutory review period and must not be conflated with the working-day timelines of the fast-track routes.
- Supplementary documentation: Article 5(b) of the Regulations provides that where the competent authority requests supplementary documents, the period spent waiting for them is added to the review period. Article 6(d) of the Medical Equipment Law further provides that after the supplementary documents are submitted, the competent authority shall continue to reach a decision under the statutory rules. The 120 days is therefore not an absolute total timeline from submission to final approval.
- Certificate issuance: Article 5(c) of the Regulations provides that the registration certificate shall be issued within 3 working days after approval.
- Fast-track routes: Fast 1 new registrations take at most 45 working days and Fast 2 new registrations at most 60 working days; fast-track renewals and changes have their own corresponding timelines, which must not be substituted with the new-registration timelines.
- Declaration route: Ministry of Health announcements state that qualifying applications can be registered immediately, provided the declaration route requirements are met and the documents are correctly submitted.
Companies therefore should not plan their launch backwards from ‘120 days’ alone. Supplementary documentation, the status of reference-country approval documents, quality system evidence, proof of actual sales and the local holder’s documentation all affect project timelines.
Legal basis: Medical Equipment Law Articles 6(c) and 6(d); Medical Equipment Regulations Article 5; AMAR REG-2024/06.
Q10 How long is the Israeli registration certificate valid, and what happens when a reference-country certificate expires?
Answer: Article 12 of the Medical Equipment Regulations provides:
- General medical devices: registration for a period not exceeding 5 years;
- Implants: a registration period of 3 years;
- Products registered or approved for sale in a recognized state: based on the validity of the registration or licence in that recognized state, but the Israeli registration period may not exceed 5 years from the date of Israeli registration.
This means the validity of the reference-country certificate affects the term of the Israeli registration certificate. Where a reference-country registration is revoked or deleted, Article 9 of the Medical Equipment Law also empowers the competent authority to take regulatory measures such as prohibiting sale or deleting the registration.
However, not every change in the status of a reference-country certificate should be described as ‘the Israeli registration certificate automatically and immediately becomes invalid’. Assess this in light of the validity period and conditions stated on the Israeli certificate, the actual status of the reference-country approval, and whether AMAR has made a further regulatory decision.
For the declaration route in particular, the AMAR registration certificate sets an express condition on proof of manufacturing conditions conforming to ISO 13485; if that evidence lapses and is not updated as required, the validity of the registration may be directly affected.
Management recommendation: maintain three interlinked validity ledgers – reference-country certificates, the ISO 13485 certificate and the Israeli registration certificate – and arrange renewals and certificate updates early; do not monitor only the Israeli registration certificate itself.
Legal basis: Medical Equipment Regulations Articles 12 and 19; Medical Equipment Law Article 9; AMAR REG-2023/05.
Q11 How does renewal work? Are there simplified mechanisms for low-risk products?
Answer: Renewal cannot be judged by the 2013 Regulations alone; the current AMAR REG-2024/07 must be read together with it.
(1) Standard/fast-track renewal for Class II, Class III and corresponding IVD products
- Article 8(b) of the Medical Equipment Law requires the holder to submit the renewal application at least 4 months in advance; AMAR REG-2024/07 provides that renewal applications are submitted within the four-month window before registration expiry. In practice, prepare and submit at the start of that window, and check the submission times currently open in the AMAR system.
- Standard renewal requires the holder’s declaration; fast-track renewal requires the holder’s affidavit certified by a lawyer, as required for the fast-track route.
- Updated foreign regulatory approval documents and the manufacturer’s ISO 13485 certificate should be submitted.
- For some Class IIa and FDA Class II products, submit the manufacturer’s latest periodic post-market surveillance report and undertake to make it available to the authorities as required; for Class IIb and Class III products, submit the corresponding periodic surveillance reports per procedure, for example a PSUR where applicable.
- For products not registered or approved for sale in a recognized state, submit the manufacturer’s latest post-market surveillance report, including a summary of tracking and audit activities and records of post-market improvements or corrections of defects.
If the CE certificate has not been obtained in time at the point of the renewal application, the holder must explain the reason in the application and undertake to submit it later. Where the situation meets REG-2024/07, AMAR may first grant a provisional registration valid for 6 months from the expiry date of the original certificate.
(2) Renewal for Class I and low-risk IVDs registered via the declaration route
Class I and low-risk IVD products registered via the declaration route are renewed annually under REG-2024/07. From 1 October each year, the holder should submit the renewal declaration for the next calendar year per procedure and update the validity of the registration itself.
(3) Continued-sale notification for low-risk non-sterile medical devices
Article 8 of the Medical Equipment Regulations provides a separate simplified mechanism for low-risk non-sterile medical devices listed in the UK MHRA Class 1 Non Sterile list:
- The continued-sale notification must be submitted at least 30 days before registration expiry;
- The information and documents in the original registration application must not have changed in any way;
- The prescribed holder and manufacturer information, a summary of post-market tracking and audit activities, and the relevant declarations must be submitted;
- The holder must declare that no special event under the Regulations has occurred and that no market withdrawal has been carried out;
- If AMAR raises no objection within 14 working days of receiving the notification, the registration is deemed extended by 5 years.
This mechanism is not the same system as the annual renewal for Class I declaration-route registrations, and the two must not be conflated.
(4) Deciding not to renew
Under Article 14 of the Regulations, where the holder does not apply for renewal, it must notify the competent authority in writing before registration expiry, stating the reasons for not renewing and whether sufficient alternative products exist on the market, issue a cessation-of-sale notice to medical institutions and the public, and submit a copy to the competent authority.
Legal basis: Medical Equipment Law Article 8; Medical Equipment Regulations Articles 7, 8 and 14; AMAR REG-2024/07.
Q12 What are the requirements for manufacturing and the quality management system?
Answer: Distinguish the requirements for the manufacturer, the Israeli registration holder, and the warehousing and transport entity.
Manufacturer and manufacturing sites: Article 19(a) of the Medical Equipment Regulations requires that medical devices marketed in Israel be manufactured in a factory with appropriate manufacturing conditions, holding a certificate issued by the health authority of the country of manufacture or another competent body confirming that the manufacturing conditions conform to ISO 13485. Devices manufactured in Israel itself must also comply with approval by the local recognised body and the corresponding manufacturing business licence requirements.
Israeli registration holder: AMAR REG-2024/03 requires proof of the holder’s quality management system; ISO 9001, GMP or equivalent documents are accepted, and the business licence must also be provided where applicable.
Warehousing and transport entity: Article 20 of the Regulations requires the entity responsible for storage and transport to obtain approval from a body recognised by the competent authority confirming conformity with ISO 9001, and to hold the applicable warehousing and transport business licence.
Note that FDA 510(k), FDA establishment registration or product listing cannot automatically replace the manufacturer’s manufacturing conditions evidence required by Israel. For ISO 13485 certificates, check the certification body’s credentials, the manufacturing sites and product scope covered, and the validity period; do not assume that all quality system documentation requirements are met on the basis of a single CE certificate.
Legal basis: Medical Equipment Regulations Articles 19 and 20; AMAR REG-2024/03.
Q13 Which languages must the labelling use? Can professional-use products be English-only?
Answer: Article 23(a) of the Medical Equipment Regulations provides that for medical devices marketed in Israel, the packaging or the instructions inside the packaging must, as required by the competent authority, clearly, unambiguously and indelibly state the relevant information in Hebrew, Arabic and English.
The main content includes:
- The product trade name;
- Intended use and indications;
- The manufacturer’s name and country of manufacture;
- The holder’s name, address and public enquiry telephone number;
- Warnings, use restrictions and safe-use information;
- Lot number or serial number and date of manufacture;
- Expiry date (where applicable);
- Quantity inside the packaging;
- For products containing pharmaceutical substances, the active ingredients and the quantity per dose must be marked as required;
- Other markings required by the registration certificate.
Article 23(b) of the Regulations also requires the product itself to be marked with the lot number, the serial number (if any), the date of manufacture and other markings specified in the registration certificate.
Professional-use products are not automatically exempt from the three-language requirement. Under Article 23(c), the distributor may apply; only after the competent authority confirms that the product is not intended for household users and that the exemption will not affect safe use may the three-language labelling requirement be waived in whole or in part.
The correct understanding is therefore: professional-use products may apply for an exemption; it is not that professional-use products may of course use English only.
Legal basis: Medical Equipment Regulations Article 23(a)-(c).
Q14 Once registered, can the product be sold and imported right away?
Answer: Registration and import approval need to be considered together, but they should not be simplistically understood as two entirely independent product registration reviews.
Article 17 of the Medical Equipment Regulations provides that after the competent authority completes the registration of the medical equipment, it shall provide the registration holder or its authorised agent with the import approval for that device to enter Israel. Companies should therefore confirm the importing entity, the registration holder and the authorisation relationship, and ensure the import documents are consistent with the registration information.
In addition, Article 23 of the Medical Equipment Law supplements Article 16 of the Standards Law, authorising the Minister of Health, for specific categories of medical devices, to waive all or part of official standards conformity testing and to require replacement with documents evidencing conformity with international or standardised standards.
This authorisation is not a blanket exemption for all medical devices. Whether testing against a specific standard can be waived should be judged together with the applicable standard, the product category and the specific orders or requirements issued by the competent authority; holding an AMAR registration certificate alone does not create a presumption that all import standards testing has been waived.
Legal basis: Medical Equipment Regulations Article 17; Medical Equipment Law Article 23 and Standards Law Article 16(c).
Q15 How should design changes, labelling changes or a change of manufacturing site after registration be handled?
Answer: Assess under Article 15 of the Medical Equipment Regulations together with AMAR REG-2024/08; the changes cannot simply be split into a ‘notification’ category and an ‘approval’ category.
Article 15(a) of the Regulations provides that when the holder becomes aware of a change to any matter listed in Article 3(a), it must notify the competent authority and the relevant medical institutions as soon as possible through the contact person or the qualified professional. Article 15(b) provides that where a change to a matter listed in Article 3 is planned, an application for change approval must be submitted under Article 6.
AMAR REG-2024/08 further classifies the changes to be handled as:
- Major changes: changes that may affect product safety, quality or effectiveness; AMAR approval is usually required before implementing the change in Israel.
- Minor changes: assessed by the manufacturer for the impact on safety, quality and effectiveness, with the need and timing of an application determined per procedure.
- Administrative changes: mainly administrative updates to registration information or certificate content.
Pay special attention to the following situations:
- Changing the intended use of the product;
- Raising the product risk class (certain classification changes arising from the transition to new EU legislation are assessed separately per procedure);
- Adding new products that are not part of the registered models, accessories or system;
- Changing the pharmaceutical substances in a device containing pharmaceutical substances.
These situations usually require a new registration application before sale, rather than being handled as ordinary changes.
REG-2024/08 also makes clear that some changes not affecting product safety, quality or effectiveness – for example adjusting only label fonts or colours, or adding or removing barcodes – may not require a change application. For some non-substantive or administrative changes that do not affect the certificate information and do not arise from safety corrective actions, the procedure allows implementation first under specified conditions, with the change documents submitted together with the renewal.
For products registered on the basis of recognized-state approvals, note a further special rule: REG-2024/08 provides that such products usually submit change applications only when the foreign regulatory approval documents or the Declaration of Conformity (DoC) are updated, when the manufacturer’s quality system certificate changes, or when the registration information needs an administrative update. The manufacturer must still assess the changes to the product itself under the reference-country regulations and the AMAR change procedure and keep the corresponding records; ‘no Israeli change application needed’ must not be read as ‘no safety, quality and effectiveness assessment of the product change needed’.
The fast-track change routes also have limits: Class II, Class IIa, Class IIb and the corresponding IVD classes may apply for different levels of fast-track changes per procedure; major changes to Class III products cannot universally use Fast 2 – the procedure provides fast-track arrangements only for their non-substantive or administrative changes.
Practical recommendation: for every change, first have the manufacturer assess the impact on safety, quality and effectiveness, then have the holder determine against REG-2024/08 whether a new registration, a change application, a notification or an update at renewal is needed. Do not implement a substantive change that may require approval first and report it afterwards.
Legal basis: Medical Equipment Regulations Articles 6 and 15; AMAR REG-2024/08 and REG-2024/06.
Part 4 | Post-Market Compliance and Special Situations
Q16 What continuing obligations apply after registration?
Answer: The registration certificate is not a one-off licence. The holder and the manufacturer must continuously maintain the product’s safety, quality, regulatory approvals and supply chain information.
This mainly includes:
- Post-market tracking and audit: Article 11 of the Medical Equipment Law lists the holder’s obligation to conduct product tracking and audit in order to assess and improve product safety and quality, and to report the related activities and information to the competent authority as required.
- Special event reporting: establish a mechanism to identify, assess and report the special events listed in the Law; see Q17 for the scope.
- Renewal evidence: Article 7 of the Medical Equipment Regulations requires a summary of tracking and audit activities at renewal; AMAR REG-2024/07 further requires the corresponding periodic post-market surveillance reports according to the risk class and the reference-country approval status.
- Traceable distribution chain: Article 24 of the Regulations provides that when required by the competent authority, the holder must provide the identity information of the distributors to which the devices were supplied, and keep the relevant documents for at least three years, counted from the date the batch was handed over.
- Response to regulatory measures: Article 12 of the Law allows the competent authority, where it considers that the product or related promotion may endanger public health, to take measures such as stopping manufacture or sale, restricting use, restricting promotion, and recall.
Post-market surveillance cannot rely solely on the manufacturer’s complaint handling. The manufacturer and the Israeli holder should establish an information transfer mechanism to ensure that overseas recalls, regulatory warnings, product corrective actions and new safety information reach the locally responsible party in time.
Legal basis: Medical Equipment Law Articles 11 and 12; Medical Equipment Regulations Articles 7 and 24; AMAR REG-2024/07.
Q17 How broad is the special event reporting scope? Which situations are easily overlooked?
Answer: Article 11(a)(3) of the Medical Equipment Law lists three categories of special events:
- Serious malfunction: a serious malfunction of a medical device occurring in Israel or another country that may endanger patient health.
- Patient harm: harm to a patient’s physical or mental health caused or suspected to have been caused by the use of the device, not being part of the normal course of disease or treatment; or significant injury or patient death caused in Israel or another country. Significant injury includes irreversible damage to body structure, function or appearance, injury requiring emergency, long-term or invasive treatment, and situations endangering life, potentially shortening life expectancy or causing congenital defects in the fetus.
- Regulatory actions and safety information: actions taken by health authorities anywhere in the world regarding the device; notices issued by the manufacturer, the holder or the health authority of any state regarding the device, its sale or its use; and new information on device safety in the major scientific literature related to medical devices.
The third category is especially easy to overlook. Companies should not start the assessment only after patient harm occurs; they should also establish a mechanism to collect global regulatory and safety information, following reference-country regulatory actions, manufacturer safety notices and new scientific information relevant to product safety.
A distinction is needed here: the statute defines the scope of special events, but the specific reporting channels, forms, reporting deadlines and submission methods should follow AMAR’s current reporting forms, the registration certificate conditions and the Ministry of Health procedures. Do not apply other countries’ 24-hour, 10-day or 15-day reporting deadlines to Israel without a current official basis.
Legal basis: Medical Equipment Law Article 11(a)(3); AMAR’s current reporting forms and registration conditions.
Q18 What legal liability may violations incur?
Answer: Articles 15 and 16 of the Medical Equipment Law provide for criminal liability and the management liability of corporate officers. The main provisions are:
| Violation | Legal liability |
|---|---|
| Manufacturing or selling a device that should be registered under the Law but is not, or manufacturing or selling in violation of the registration conditions; issuing instructions for medical use of an unregistered device or using it in medical treatment; violating regulatory directives under Article 12 | Imprisonment for up to 1 year or the statutory fine; where committed by a legal person, the fine is doubled |
| The holder failing to carry out tracking and audit as required, or failing to report special events as required | Imprisonment for up to 6 months or the statutory fine; where committed by a legal person, the fine is doubled |
| The above violations having caused or being likely to cause actual harm to public health | Imprisonment for up to 3 years or the corresponding aggravated fine; a legal person may face 5 times the fine provided by law |
| Continuing violations | After the period set in a written warning or notice from the competent authority expires, the court may, as provided by law, impose a daily fine for the continuing violation at 5% of the relevant statutory fine |
Article 16 of the Law also provides for the supervisory responsibility of corporate officers. Officers are obliged to supervise and to do everything possible to prevent the company or its employees from committing the violations under Article 15; if the company or an employee commits such a violation, the officers may be presumed to have failed their supervisory duty, unless they can prove that they made the efforts required by law.
Actual penalties depend on the nature of the violation, the applicable provisions and the determinations of the competent authority and the courts; the statutory maximum liability must not be read as the penalty automatically applied to every violation.
Legal basis: Medical Equipment Law Articles 15 and 16.
Q19 Can you still apply for Israeli registration without CE or FDA?
Answer: The law does not flatly prohibit it, but the standard route is usually required, with greater uncertainty in review and documentation preparation.
The basic registration conditions in Article 6(a) of the Medical Equipment Law include:
- The benefit of using the product outweighs the related risks;
- The product has demonstrated appropriate effectiveness and safety for its intended use;
- The product is manufactured under appropriate manufacturing conditions;
- The product name must not mislead the user in a way that may endanger public health.
Article 6(b) provides that for devices already registered or approved for sale in a recognized state and actually marketed there, the competent authority may register them based on the corresponding reference-country approval conditions and incorporate the reference-country registration conditions into the Israeli registration.
Therefore, the absence of CE or FDA approval does not mean the application is legally impossible, but note:
- The declaration route or the fast-track routes usually cannot be applied directly;
- Documentation supporting safety, effectiveness, quality and manufacturing conditions must be submitted under the standard procedure;
- AMAR may request supplementary technical documentation, risk management, clinical evaluation or other evidence according to the product risk class and product type;
- Special requirements such as the opinions of two medical experts under Article 3(c) of the Regulations target products manufactured in Israel that are not registered or approved for sale in a recognized state, and must not be applied as a uniform submission requirement for all foreign-manufactured products.
Strategy recommendation: if the company already has plans for a global market footprint, it should evaluate at the product development and registration planning stage whether to first obtain approvals in reference markets such as the EU or the US. Reference-country approval is not a statutory precondition for every product entering Israel, but it usually helps clarify classification and reduce documentation gaps and review uncertainty.
Legal basis: Medical Equipment Law Articles 6(a) and 6(b); Medical Equipment Regulations Article 3(c); AMAR REG-2024/03.
Q20 What happens if the documentation is incomplete? Can you resubmit after rejection?
Answer: Article 11 of the Medical Equipment Regulations sets a rather strict mechanism for incomplete applications:
- The application must be submitted complete with all required documents and forms; where the documentation is incomplete, the competent authority may refuse to accept or process it and reject it directly, without further explanation.
- After an application is rejected, fees already paid are in principle not refunded; the same application may not be resubmitted within one month from receipt of the rejection notice.
- If the same application is resubmitted twice after the initial rejection and rejected again for incompleteness – i.e. three incomplete rejections in total – any further submission requires the written approval of the competent authority, with reasons stated.
- The Regulations also provide that where a fee-paid application is rejected for incompleteness, resubmitting the same application within 6 months after the rejection notice is issued incurs no additional fees.
Read the above rules together with the current fee situation: an official Ministry of Health announcement shows that from 15 August 2022, no application fees are charged for medical device registration, change and renewal applications. The refund and duplicate-payment rules in the Regulations therefore remain part of the legal text, but it cannot be inferred from them that every registration application currently requires an application fee. Check AMAR’s latest announcements and application forms again before submission.
Before submission, verify item by item:
- Whether the Israeli applicant, contact person and business licence information is complete;
- Whether the holder’s ISO 9001 or GMP documents meet the current procedure;
- Whether the manufacturer’s and manufacturing sites’ ISO 13485 or GMP certificates are valid and cover the correct scope;
- Whether the foreign regulatory approvals, proof of actual sales and certificate validity meet the chosen route;
- Whether the product models, intended use, indications, labelling and instructions for use are consistent;
- Whether risk management, clinical evaluation, electrical safety, EMC, sterilisation, biocompatibility and software verification documents are submitted according to product type;
- Whether the declaration, the affidavit and the application form use the current versions.
Legal basis: Medical Equipment Regulations Article 11; Ministry of Health AMAR announcements; AMAR REG-2024/03.
Closing: the five compliance red lines for Israeli registration
- Entity red line: the registration applicant must meet the Israeli resident or locally registered company requirement. The holder arrangement must be settled before the project starts; do not wait until submission to remedy it.
- Route red line: fast-track eligibility is not just about holding CE or FDA certificates; verify the specific approval type, the independence of the regulatory authorities and the actual sales history.
- Quality system red line: the manufacturer, the Israeli holder and the warehousing and transport entity bear different quality system and licensing requirements; one certificate cannot replace the obligations of all parties.
- Renewal red line: reference-country approvals, the ISO 13485 certificate, the Israeli registration certificate and the post-market surveillance reports must be managed in sync; do not focus only on the expiry date on the Israeli registration certificate.
- Post-registration red line: changes, regulatory actions, special events, labelling updates and distribution traceability are all continuing compliance work; they do not end once the registration certificate has been obtained.
Disclaimer and regulatory verification notes
- This article is compiled from Israel’s Medical Equipment Law, the 2013 Medical Equipment Regulations and the current procedural documents of the Ministry of Health AMAR available as of 16 November 2026.
- The official Hebrew text of Israeli laws and regulations is legally binding. The English text of this article is for industry information exchange and does not replace the Hebrew originals or formal legal advice.
- AMAR procedural documents, application forms and related announcements may be updated. The recognized-state list, registration routes, application documentation, and renewal and change requirements should be re-verified before project submission.
- This article is a compilation of regulatory information for the medical device industry and does not constitute legal advice on specific products or a guarantee of registration outcomes. Specific projects should be assessed in light of the product’s intended use, technical characteristics, reference-country approval status and actual sales.
Official legal and procedural document references
The following prioritises publicly available materials from the Israeli Knesset and the Ministry of Health:
- Knesset national laws database: Medical Equipment Law 5772-2012 – https://main.knesset.gov.il/Activity/Legislation/Laws/Pages/LawPrimary.aspx?lawitemid=2001170
- Original legal text of the Medical Equipment Law published by the Israeli Ministry of Health (Hebrew) – https://www.gov.il/BlobFolder/legalinfo/standards_law/he/laws_standards-law_law2357.pdf
- AMAR medical device registration announcements and procedure updates – https://www.gov.il/he/pages/amar-announcements
- AMAR REG-2024/03: medical equipment registration documentation requirements – https://www.gov.il/BlobFolder/dynamiccollectorresultitem/registration-procedure-medical-equipment-register_documents-registration/he/units_amar_Registration-procedure-medical-equipment-register_documents-registration.pdf
- AMAR REG-2024/06: fast-track registration procedure – https://www.gov.il/BlobFolder/dynamiccollectorresultitem/fast-track-registration-procedure-medical-equipment-register/he/units_amar_Fast-track-registration-procedure-medical-equipment-register.pdf
- AMAR REG-2024/07: registration renewal procedure – https://www.gov.il/BlobFolder/dynamiccollectorresultitem/procedure-renewal-registration-medical-equipment-register/he/units_amar_Procedure-renewal-registration-medical-equipment-register.pdf
- AMAR REG-2024/08: registration change procedure – https://www.gov.il/BlobFolder/dynamiccollectorresultitem/procedure-changing-registration-medical-equipment-register/he/units_amar_Procedure-changing-registration-medical-equipment-register.pdf
- AMAR REG-2023/04: declaration route registration procedure – https://www.gov.il/BlobFolder/dynamiccollectorresultitem/guidelines-for-registering-medical-equipment-declaration-route/he/units_amar_guidelines-for-registering-medical-equipment-declaration-route.pdf
- AMAR REG-2023/05: registration certificate format and content – https://www.gov.il/BlobFolder/dynamiccollectorresultitem/format-procedure-wording-certificate-registration-medical-equipment-register/he/units_amar_format-procedure-wording-certificate-registration-medical-equipment-register.pdf